Liwei Shu

机构：Sir Run Run Shaw Hospital, Zhejiang University · ORCID：0000-0002-9641-1490

发表论文 7 篇 · 总被引 144 次 · h-index 4

代表论文

New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer (2020 · Chemistry - A European Journal · 被引 66)
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models (2023 · Advanced Science · 被引 35)
Niacin-ligated platinum( iv )–ruthenium( ii ) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo (2020 · Chemical Communications · 被引 29)
Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy (2021 · International Journal of Pharmaceutics · 被引 13)
Cover Feature: New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer (Chem. Eur. J. 66/2020) (2020 · Chemistry - A European Journal · 被引 1)
Corrigendum to “Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy” [Int. J. Pharm. 605 (2021) 120805] (2023 · International Journal of Pharmaceutics)